Synthesis and pharmacology of site-specific cocaine abuse treatment agents: Restricted rotation analogues of methylphenidate

Journal of Medicinal Chemistry

Volumn 50, Issue 11, 2007, Pages 2718-2731

  Kim, Deog Il ^a   Deutsch, Howard M ^a   Ye, Xiaocong ^a   Schweri, Margaret M ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; COCAINE; DECANE; DOPAMINE; METHYLPHENIDATE; NISOXETINE; QUINOLIZIDINE DERIVATIVE; SEROTONIN; THRE 1 AZA 3 5 PHENYL[4.4.0]DECANE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; COCAINE DEPENDENCE; DRUG STRUCTURE; DRUG SYNTHESIS; SYNTHESIS; WITTIG REACTION;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; CITALOPRAM; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FLUOXETINE; MALE; METHYLPHENIDATE; QUINOLIZINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34250175092     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm061354p     Document Type: Article

References (36)

1. Karch, S.B. A Brief History of Cocaine; 2nd ed.; CRC Press LLC: New York, 2006.
2. Principles of HIV Prevention in Drug-Using Populations, A Research-Based Guide; NIH Publication No. 02-4733, Mar 2002.
3. (a) The Economic Costs of Drug Abuse in the United States (1992-1998), Executive Office of the President Office of National Drug Control Policy: Washington, D.C., Sept 2001.
4. (b) SAMHSA. National Household Survey on Drug Abuse: Main Findings 1996; DHHS Pub. No. (SMA) 98-3200; Substance Abuse and Mental Health Services Administration: Rockville, MD, 1998.
5. (c) NIDA Research Report-Cocaine Abuse and Addiction, NIH Publication No 99-4342, May 1999.
6. Singh, S. Chemistry, Design, and Structure-Activity Relationship of Cocaine Antagonists. Chem. Rev. 2000, 100, 925-1024.
7. Ritz, M. C.; Lamb, R. J.; Goldberg, S. R.; Kuhar, M. J. Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine. Science 1987, 237, 1219-223.
8. Rocha, B. A.; Scearce-Levie, K.; Lucas, J. J.; Hiroi, N.; Castanon, N.; Crabbe, J. C.; Nestler, E. J.; Hen, R. Increased Vulnerability to Cocaine in Mice Lacking the Serotonin-1B Receptor. Nature 1998, 393, 175-178.
9. Carroll, F. I.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. Cocaine Receptor: Biochemical Characterization and Structure- Activity Relationships of Cocaine Analogues at the Dopamine Transporter. J. Med. Chem 1992, 35, 969-981.
10. Carroll, F. I.; Gao, Y.; Rahman, M. A.; Abraham, P.; Parham, K.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. Synthesis, Ligand Binding, QSAR, and CoMFA Study of 3β-(p-Substituted phenyl)tropane-2β-carboxylic Acid Methyl Esters. J. Med. Chem., 1991, 34, 2719-2725.
11. Kozikowski, A. P.; Araldi, G. L.; Boja, J.; Meil, W. M.; John, K. M.; Flippen-Anderson, J. L.; George, C.; Saiah, E. Chemistry and Pharmacology of the Piperidine-Based Analogues of Cocaine. Identification of Potent DAT Inhibitors Lacking the Tropane Skeleton. J. Med. Chem. 1998, 41, 1962-1969.
12. Petukhov, P. A.; Zhang, J.; Kozikowski, A. P.; Wang, C. Z.; Ye, Y. P.; Johnson, K. M.; Tella, S. R. SAR Studies of Piperidine-Based Analogues of Cocaine. 4. Effect of N-Modification and Ester Replacement. J. Med. Chem. 2002, 45, 3161-3170.
13. Smith, M. P.; Johnson, K. M.; Zhang, M.; Flippen-Anderson, J. L.; Kozikowski, A. P. Tuning the Selectivity of Monoamine Transporter Inhibitors by the Stereochemistry of the Nitrogen Lone Pair. J. Am. Chem. Soc. 1998, 120, 9072-9073.
14. Zhang A.; Zhou, G.; Hoepping, A.; Mukhopadhyaya, J.; Johnson, K. M.; Zhang, M.; Kozikowski, A. P. Further Studies on Conformationally Constrained Tricyclic Tropane Analogues and Their Uptake Inhibition at Monoamine Transporter Sites: Synthesis of (Z)-9-(Substituted arylmethylene)-7-azatricyclo[4.3. 1.0 (3,7)]decanes as a Novel Class of Serotonin Transporter Inhibitors. J. Med. Chem., 2002, 45, 1930-1941.
15. Kollins, S. H.; MacDonald, E. K.; Rush, C. R. Assessing the Abuse Potential of Methylphenidate in Nonhuman and Human Subjects - A Review. Pharmacol. Biochem. Behav. 2001, 68, 611-627.
16. Challman, T. D.; Lipsky, J. J. Methylphenidate: Its Pharmacology and Uses. Mayo Clin. Proc. 2000, 75, 711-721.
17. Pan, D.; Gatley, S. J.; Dewey, S. L.; Chen, R.; Alexoff, D. A.; Ding, Y.-S.; Fowler, J. S. Binding of Bromine-Substituted Analogs of Methylphenidate to Monoamine Transporters. Eur. J. Pharmacol. 1994, 264, 177-182.
18. Deutsch, H. M.; Shi, Q.; Gruszecka-Kowalik, E.; Schweri, M. M. Synthesis and Pharmacology of Potential Cocaine Antagonists. 2. Structure-Activity Relationship Studies of Aromatic Ring-Substituted Methylphenidate Analogs. J. Med. Chem., 1996, 39, 1201-1209.
19. Catterall, W.A.; Mackie, K. Local anesthetics. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed.; Brunton, L.L; Lazo, J.S.; Parker, K.L., Eds.; McGraw-Hill: New York, 2006; pp 376-377.
20. (a) Temple, D. L.; Sam, J. 1-Arylquinolizidines. J. Heterocycl. Chem. 1970, 7, 847-855.
21. (b) Bogeso, K. P.; Arnt, J.; Lundmark, M.; Sundell, S. Indolizidine and Quinolizidine Derivatives of the Dopamine Autoreceptor Agonist 3-(3-Hydroxyphenyl)-N-n-propylpiperazine (3-PPP). J. Med. Chem. 1987, 30, 142-150.
22. Vedejs, E.; Fleck, T.; Hara, S. Evidence against Reversible Wittig Reaction of a Stabilized Ylide: High (E)-Olefin Selectivity under Kinetic Control. J. Org. Chem. 1987, 52, 4637-4639.
23. Mitsunobu, O. Review of the Mitsunobu Reaction. Org. Synth. 1981, 1-28.
24. 3-SiCl/HMPA Accelerated Conjugate Addition of Catalytic Copper Reagent. Stereoselective Synthesis of Enol Silyl Ether of Aldehyde. Tetrahedron Lett. 1986, 27, 4025.
25. Freifelder, M.; Robinson, R. M.; Stone, G. R. Hydrogenation of Substituted Pyridines with Rhodium on Carbon Catalyst. J. Org. Chem. 1962, 27, 284-286.
26. Amat, M.; Cantó, M.; Llor, N.; Escolano, C.; Molins, E.; Espinosa, E.; Bosch, J. Dynamic Kinetic Resolution of Racemic γ-Aryl-δ- oxoesters. Enantioselective Synthesis of 3-Arylpiperidines. J. Org. Chem. 2002, 67, 5343-5351.
27. (a) Reith, M. E. A.; Selmeci, G. Radiolabeling of Dopamine Uptake Sites for Cocaine, Mazindaol, and GBR 12935. Naunyn-Schmiedberg's Arch. Pharmacol. 1992, 345, 309-318.
28. (b) Schweri, M. M.; Jacobson, A. E.; Lessor, R. A.; Rice, K. C. Metaphit inhibits dopamine transport and binding of [(3)H]methylphenidate, a proposed marker for the dopamine transport complex. Life Sci. 1989, 45, 1689-1698.
29. Carroll, F. I.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. Cocaine Receptor: Biochemical Characterization and Structure-Activity Relationships of Cocaine Analogues at the Dopamine Transporter. J. Med. Chem. 1992, 35, 969-981.
30. Robarge, M. J.; Agoston, G. E.; Izenwasser, S.; Kopajtic, T.; George, C.; Katz, J. L.; Newman, A. H. Highly Selective Chiral N-Substituted 3a-[Bis(4′-fluorophenyl)methoxy]tropane Analogues for the Dopamine Transporter: Synthesis and Comparative Molecular Field Analysis. J. Med. Chem. 2000, 43, 1085-1093.
31. Rhoden, J. B; Bouvet, M.; Izenwasser, S.; Wade, D.; Lomenzo, S. A.; Trudell, M. L. Structure - Activity Studies of 3′-4′- Dichloromeperidine Analogues at Dopamine and Serotonin Transporters. Bioorg., Med. Chem. 2005, 13, 5623-5634.
32. a. Meltzer, P. C.; Blundell, P.; Yong, Y. F.; Chen, Z.; George, C.; Gonzalez, M. D.; Madras, B. K. 2-Carbomethoxy-3-aryl-8-bicyclo-[3.2.1]octanes: Potent Non-Nitrogen Inhibitors of Monoamine Transporters. J. Med. Chem. 2000, 43, 2982-2991.
33. b. Meltzer, P. C.; Wang, P. L.; Blundell, P.; Madras, B. K. Synthesis and Evaluation of Dopamine and Serotonin Transporter Inhibition by Oxacyclic and Carbacyclic Analogues of Methylphenidate. J.Med.Chem. 2003, 46, 1538-1545.
34. Deutsch, H. M.; Collard, D. M.; Zhang, L.; Burnham, K. S.; Deshpande, A. K.; Holtzman, S. G.; Schweri, M. M. Synthesis and Pharmacology of Site-Specific Cocaine Abuse Treatment Agents: 2-(Aminomethyl)-3-phenylbicyclo[2.2.2]- and -[2.2.1]alkane Dopamine Inhibitors. J. Med. Chem. 1999, 42, 882-895.
35. Dutta, A. K.; Fei, X.-S.; Beardsley, P. M.; Newman, J. L.; Reith, M. E. A. Structure-Activity Relationship Studies of 4-[2-(Diphenylmethoxy)Ethyl]-1- Benzylpiperidine Derivatives and their N-Analogues: Evaluation of Behavioral Activity of O- And N-Analogues and their Binding to Monoamine Transporters. J. Med. Chem. 2001, 44, 937-948.
36. Schweri, M. M.; Deutsch, H. M.; Massey, A. T.; Holtzman, S. G. Biochemical and Behavioral Characterization of Novel Methylphenidate Analogs. J. Pharmacol. Exp. Ther. 2002, 301, 527-535.